Some studies adopted a broad approach by examining associations with “all solid tumors.” In contrast, others focused on specific anatomical sites or employed surrogate markers for cancer outcomes, such as prostate-specific antigen (PSA) levels or mortality data. The gene discussed is KLK3; the disease is cancer.